Form 4 for OTLK Outlook Therapeutics, Inc.
Accepted 2024-09-30 00:00:00 ET · period of report 2024-09-26 · accession 0001415889-24-024093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2024-09-26 | OTLK | KENYON LAWRENCE A | CFO, Dir | P - Purchase | $5.69 | +5,000 | 5,946 | +529% | +$28.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-26 | P | A | 5,000 | $5.69 | 5,946 | D | — | — | (F1) Reflects the Issuer's 1-for-20 reverse stock split effected on March 13, 2024. |